{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:16:55Z","timestamp":1788466615502,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5T32AI007061"],"award-info":[{"award-number":["5T32AI007061"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.idc.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T19:45:18Z","timestamp":1667245518000},"page":"719-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock"],"prefix":"10.1016","volume":"36","author":[{"given":"Theodore R.","family":"Pak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanu","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Klompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.idc.2022.08.001_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/CCM.0000000000002538","article-title":"Revised National Estimates of Emergency Department Visits for Sepsis in the United States","volume":"45","author":"Wang","year":"2017","journal-title":"Crit Care Med"},{"issue":"13","key":"10.1016\/j.idc.2022.08.001_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.idc.2022.08.001_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","article-title":"The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis","volume":"43","author":"Sterling","year":"2015","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.idc.2022.08.001_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.chest.2019.02.008","article-title":"Door-to-Antibiotic Time and Long-term Mortality in Sepsis","volume":"155","year":"2019","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.idc.2022.08.001_bib6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","article-title":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program","volume":"42","author":"Ferrer","year":"2014","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2022.08.001_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The Timing of Early Antibiotics and Hospital Mortality in Sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2022.08.001_bib8","author":"Centers for Medicare & Medicaid Services"},{"issue":"23","key":"10.1016\/j.idc.2022.08.001_bib9","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to Treatment and Mortality during Mandated Emergency Care for Sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2022.08.001_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2022.08.001_bib11","series-title":"One boy\u2019s death moves state to action to prevent others","author":"Dwyer","year":"2012"},{"issue":"8","key":"10.1016\/j.idc.2022.08.001_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.idc.2022.08.001_bib14","first-page":"1","article-title":"Evidence underpinning the centers for medicare & medicaid services\u2019 severe sepsis and septic shock management bundle (SEP-1) a systematic review","volume":"168","author":"Pepper","year":"2018","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.idc.2022.08.001_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/cix997","article-title":"Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines","volume":"66","author":"Kalil","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-1035-1","article-title":"Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: A cohort study","volume":"19","author":"Klein Klouwenberg","year":"2015","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib17","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/CCM.0000000000005090","article-title":"Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department","volume":"49","author":"Shappell","year":"2021","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib18","doi-asserted-by":"crossref","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.idc.2022.08.001_bib19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of Adverse Events With Antibiotic Use in Hospitalized Patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2022.08.001_bib20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/cid\/cix186","article-title":"Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study","volume":"64","author":"Ong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.08.001_bib21","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/infdis\/jiaa146","article-title":"A\u00a0critical analysis of the literature on time-to-antibiotics in suspected sepsis","volume":"222","author":"Weinberger","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/ciaa059","article-title":"Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure","volume":"72","author":"Rhee","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2213-2600(17)30469-1","article-title":"Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial","volume":"6","author":"Alam","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","article-title":"Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial","volume":"43","author":"Bloos","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.chest.2021.06.029","article-title":"Antibiotic Timing and Progression to Septic Shock Among Patients in the ED With Suspected Infection","volume":"161","author":"Bisarya","year":"2022","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0263936","article-title":"Hour-1 bundle adherence was associated with reduction of in-hospital mortality among patients with sepsis in Japan","volume":"17","author":"Umemura","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13054-022-03901-9","article-title":"Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial","volume":"26","author":"R\u00fcddel","year":"2022","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.idc.2022.08.001_bib28","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/CCM.0000000000003260","article-title":"Presenting symptoms independently predict mortality in septic shock: Importance of a previously unmeasured confounder","volume":"46","author":"Filbin","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib29","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1097\/CCM.0000000000002311","article-title":"The absence of fever is associated with higher mortality and decreased antibiotic and IV fluid administration in emergency department patients with suspected septic shock","volume":"45","author":"Henning","year":"2017","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A\u00a0modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"Van Walraven","year":"2009","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.idc.2022.08.001_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.idc.2022.08.001_bib33","first-page":"1","article-title":"Prevalence and Outcomes of Previously Healthy Adults Among Patients Hospitalized With Community-Onset Sepsis","author":"Alrawashdeh","year":"2022","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.idc.2022.08.001_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The Surviving Sepsis Campaign Bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chest.2018.10.008","article-title":"POINT: Should the Surviving Sepsis Campaign Guidelines Be Retired?","volume":"155","author":"Marik","year":"2019","journal-title":"Yes Chest"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5811\/westjem.2018.11.39290","article-title":"Challenging the one-hour sepsis bundle","volume":"20","author":"Kalantari","year":"2019","journal-title":"West J Emerg Med"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.annemergmed.2019.01.030","article-title":"Challenging the One-Hour Bundle Goal for Sepsis Antibiotics","volume":"73","author":"Talan","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chest.2018.10.012","article-title":"Steering and Executive Committee of the Surviving Sepsis Campaign. COUNTERPOINT: Should the Surviving Sepsis Campaign Guidelines Be Retired? No","volume":"155","author":"Levy","year":"2019","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.idc.2022.08.001_bib40","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.5833","article-title":"Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: A randomized trial","volume":"307","author":"Brunkhorst","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2022.08.001_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.CCM.0B013E31816203D6","article-title":"Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia","volume":"36","author":"Heyland","year":"2008","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib42","first-page":"331","article-title":"Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis \u2013 A systematic review with meta-analysis and trial sequential analysis","volume":"74","author":"Sj\u00f6vall","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00134-020-05929-3","article-title":"Antimicrobial-associated harm in critical care: a narrative review","volume":"46","author":"Arulkumaran","year":"2020","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib44","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00057-2019","article-title":"Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: A cohort study","volume":"54","author":"Webb","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.idc.2022.08.001_bib46","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00141110","article-title":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia","volume":"38","author":"Attridge","year":"2011","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.idc.2022.08.001_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(10)70314-5","article-title":"Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: An observational, multicentre cohort study","volume":"11","author":"Kett","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.08.001_bib48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","article-title":"Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: A quasi-experimental, before and after observational cohort study","volume":"12","author":"Hranjec","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2022.08.001_bib50","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/CCM.0000000000004669","article-title":"The Goldilocks Effect in the ICU\u2014When the Data Speak, but Not the Truth","volume":"48","author":"Leisman","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2021.02.006","article-title":"Early Care of Adults With Suspected Sepsis in the Emergency Department and Out-of-Hospital Environment: A Consensus-Based Task Force Report","volume":"78","author":"Yealy","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib52","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib53","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","article-title":"Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.idc.2022.08.001_bib54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1017\/ice.2018.134","article-title":"Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure","volume":"39","author":"Rhee","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13054-018-2279-3","article-title":"Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis","volume":"22","author":"Zhang","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.idc.2022.08.001_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcrc.2018.06.012","article-title":"Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study","volume":"47","author":"G\u00e5rdlund","year":"2018","journal-title":"J\u00a0Crit Care"},{"issue":"10","key":"10.1016\/j.idc.2022.08.001_bib57","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/CCM.0000000000005054","article-title":"Identifying High-Risk Subphenotypes and Associated Harms From Delayed Antibiotic Orders and Delivery","volume":"49","author":"Han","year":"2021","journal-title":"Crit Care Med"},{"issue":"20","key":"10.1016\/j.idc.2022.08.001_bib58","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2022.08.001_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jamia\/ocz211","article-title":"On classifying sepsis heterogeneity in the ICU: Insight using machine learning","volume":"27","author":"Ibrahim","year":"2020","journal-title":"J\u00a0Am Med Inform Assoc"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib61","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: Time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib63","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.chest.2018.12.029","article-title":"Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis","volume":"155","author":"Pepper","year":"2019","journal-title":"Chest"},{"issue":"0","key":"10.1016\/j.idc.2022.08.001_bib64","first-page":"1","article-title":"Antibiotics duration guided by biomarkers in hospitalized adult patients; a systematic review and meta-analysis","volume":"0","author":"Elnajdy","year":"2022","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.idc.2022.08.001_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-9-161","article-title":"Rapid identification of bacterial pathogens using a PCR- and microarray-based assay","volume":"9","author":"J\u00e4rvinen","year":"2009","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2022.08.001_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1203\/01.PDR.0000169580.64191.8B","article-title":"Rapid diagnosis of bacterial sepsis with PCR amplification and microarray hybridization in 16S rRNA gene","volume":"58","author":"Shang","year":"2005","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib67","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1099\/jmm.0.000168","article-title":"Rapid identification of bacteria from positive blood culture bottles by MALDI-TOF MS following short-term incubation on solid media","volume":"64","author":"Altun","year":"2015","journal-title":"J\u00a0Med Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2022.08.001_bib68","article-title":"Direct microorganism species identification and antimicrobial susceptibility tests from positive blood culture bottles using rapid Sepsityper Kit","volume":"2021","author":"Watanabe","year":"2022","journal-title":"J\u00a0Infect Chemother"},{"issue":"5","key":"10.1016\/j.idc.2022.08.001_bib69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jmii.2017.03.005","article-title":"A\u00a0simple method for rapid microbial identification from positive monomicrobial blood culture bottles through matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"51","author":"Lin","year":"2018","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"11","key":"10.1016\/j.idc.2022.08.001_bib70","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/cid\/civ670","article-title":"How Next-Generation Sequencing and Multiscale Data Analysis Will Transform Infectious Disease Management","volume":"61","author":"Pak","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.08.001_bib71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","article-title":"Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters","volume":"46","author":"Sweeney","year":"2018","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2022.08.001_bib72","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat Med"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:26Z","timestamp":1760196566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0891552022000599"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.08.001","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}